Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,299 INR | -2.43% | -3.82% | -4.23% |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Mar. 28 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.23% | 1.18B | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India